China Pharmacogenetic Testing Market to 2032
Overview
The China Pharmacogenetic Testing Market is expected to reach a 381.31 USD Million by 2032 and is projected to grow at a CAGR of 14.17% from 2025 to 2032.
Revenue, 2024 (USD Million)
177.96
Forecast, 2032 (USD Million)
381.31
CAGR, 2024 - 2032
14.17%
Report Coverage
China
China Pharmacogenetic Testing Market 2018-2032 USD Million
China Pharmacogenetic Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 177.96 USD Million
- Projected Market Size (2032): 381.31 USD Million
- CAGR (2025-2032): 14.17%
Key Findings of China Pharmacogenetic Testing Market
- The China Pharmacogenetic Testing Market was valued at 177.96 USD Million in 2024.
- The China Pharmacogenetic Testing Market is likely to grow at a CAGR of 14.17% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Blood in Sample Segment accounted for the largest share of the market with a revenue of 98.76 USD Million
- The fastest growing segment CYP2C19 in Gene Segment grew Fastest with a CAGR of 18.58% during the forecast period from 2024 to 2032.
China Pharmacogenetic Testing Market Scope
China Pharmacogenetic Testing Market Segmentation & Scope
Type
- Single Gene Tests
- Array-Based Tests
- Whole Exome Sequencing
- Whole Genome Sequencing
Gene
- Others
- TMPT
- HTR2A/C
- SLC6A4
- D4D4
- DRD3
- ONCOTYPE DX® AND MAMMAPRINT®
- OPRM1
- CYP2D
- HLA-B*5701
- HLA-B*1502
- CYP1A2
- CYP2C9 AND VKORC1
- CYP2D6
- CYP2C19
Distribution Channel
- Direct-to-Customer Services
- Mail-Order Pharmacies
- Retail Pharmacies
- Hospital Pharmacy
End User
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Healthcare Providers
Therapeutic Area
- Others
- Neurology
- Oncology
- Gynecology
- Dermatology
- Immunology & Hypersensitivity
- Endocrinology
- Genomics
- Anesthesiology
- Gastroenterology
- Cardiology
Sample
- Saliva
- Blood
Drug
- Over-the-Counter Medications
- Vitamins
- Herbal Supplements
- Recreational Drugs
- Nutraceuticals
- Prescription Drugs
Application
- Drug Regulation
- Drug Development
- Clinical Practice
China Pharmacogenetic Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 177.96 USD Million |
| Market Value in 2032 | 381.31 USD Million |
| CAGR (2025-2032) | 14.17% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Gene,Distribution Channel,End User,Therapeutic Area,Sample,Drug,Application |
Regional Insights:
-
Leading Market (2024-2032): China, leading in terms of revenue 177.96 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 177.96 USD Million in 2024.
Segments and Scope
-
China Pharmacogenetic Testing Market to 2032, By Type
- Whole Genome Sequencing is the largest segment in China Pharmacogenetic Testing Market to 2032 with a revenue of 86.76 USD Million in the year 2024.
- Whole Genome Sequencing is the Fastest growing segment in China Pharmacogenetic Testing Market to 2032 with a Growth rate of 14.75 % in forecast period 2025-2032.
-
China Pharmacogenetic Testing Market to 2032, By Gene
- CYP2C19 is the largest segment in China Pharmacogenetic Testing Market to 2032 with a revenue of 27.01 USD Million in the year 2024.
- CYP2C19 is the Fastest growing segment in China Pharmacogenetic Testing Market to 2032 with a Growth rate of 18.58 % in forecast period 2025-2032.
-
China Pharmacogenetic Testing Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in China Pharmacogenetic Testing Market to 2032 with a revenue of 82.27 USD Million in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in China Pharmacogenetic Testing Market to 2032 with a Growth rate of 14.77 % in forecast period 2025-2032.
-
China Pharmacogenetic Testing Market to 2032, By End User
- Healthcare Providers is the largest segment in China Pharmacogenetic Testing Market to 2032 with a revenue of 73.60 USD Million in the year 2024.
- Healthcare Providers is the Fastest growing segment in China Pharmacogenetic Testing Market to 2032 with a Growth rate of 14.93 % in forecast period 2025-2032.
-
China Pharmacogenetic Testing Market to 2032, By Therapeutic Area
- Cardiology is the largest segment in China Pharmacogenetic Testing Market to 2032 with a revenue of 33.72 USD Million in the year 2024.
- Cardiology is the Fastest growing segment in China Pharmacogenetic Testing Market to 2032 with a Growth rate of 17.94 % in forecast period 2025-2032.
-
China Pharmacogenetic Testing Market to 2032, By Sample
- Blood is the largest segment in China Pharmacogenetic Testing Market to 2032 with a revenue of 98.76 USD Million in the year 2024.
- Blood is the Fastest growing segment in China Pharmacogenetic Testing Market to 2032 with a Growth rate of 14.36 % in forecast period 2025-2032.
-
China Pharmacogenetic Testing Market to 2032, By Drug
- Prescription Drugs is the largest segment in China Pharmacogenetic Testing Market to 2032 with a revenue of 57.60 USD Million in the year 2024.
- Prescription Drugs is the Fastest growing segment in China Pharmacogenetic Testing Market to 2032 with a Growth rate of 15.43 % in forecast period 2025-2032.
-
China Pharmacogenetic Testing Market to 2032, By Application
- Clinical Practice is the largest segment in China Pharmacogenetic Testing Market to 2032 with a revenue of 82.05 USD Million in the year 2024.
- Clinical Practice is the Fastest growing segment in China Pharmacogenetic Testing Market to 2032 with a Growth rate of 14.69 % in forecast period 2025-2032.
China Pharmacogenetic Testing Market Company Share Analysis
| Company Name |
|
||
| Illumina, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Sonic Healthcare Limited | |||
| BGI | |||
China Pharmacogenetic Testing Market Geographical Sales Distribution, 2018-2032 USD Million
China Pharmacogenetic Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The China Pharmacogenetic Testing Market is segmented based on Segmentation Type,Gene,Distribution Channel,End User,Therapeutic Area,Sample,Drug,Application.
China Pharmacogenetic Testing Market was valued at USD 177.96(Revenue in USD Million) in 2021.
China Pharmacogenetic Testing Market is projected to grow at a CAGR of 14.17% during the forecast period of 2024 to 2032.
The Blood segment is expected to dominate the China Pharmacogenetic Testing Market, holding a largest market share of 98.76 USD Million in 2024
China Pharmacogenetic Testing Market Scope
China Pharmacogenetic Testing Market Segmentation & Scope
Type
- Single Gene Tests
- Array-Based Tests
- Whole Exome Sequencing
- Whole Genome Sequencing
Gene
- Others
- TMPT
- HTR2A/C
- SLC6A4
- D4D4
- DRD3
- ONCOTYPE DX® AND MAMMAPRINT®
- OPRM1
- CYP2D
- HLA-B*5701
- HLA-B*1502
- CYP1A2
- CYP2C9 AND VKORC1
- CYP2D6
- CYP2C19
Distribution Channel
- Direct-to-Customer Services
- Mail-Order Pharmacies
- Retail Pharmacies
- Hospital Pharmacy
End User
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Healthcare Providers
Therapeutic Area
- Others
- Neurology
- Oncology
- Gynecology
- Dermatology
- Immunology & Hypersensitivity
- Endocrinology
- Genomics
- Anesthesiology
- Gastroenterology
- Cardiology
Sample
- Saliva
- Blood
Drug
- Over-the-Counter Medications
- Vitamins
- Herbal Supplements
- Recreational Drugs
- Nutraceuticals
- Prescription Drugs
Application
- Drug Regulation
- Drug Development
- Clinical Practice
Frequently Asked Questions
The China Pharmacogenetic Testing Market is segmented based on Segmentation Type,Gene,Distribution Channel,End User,Therapeutic Area,Sample,Drug,Application.
China Pharmacogenetic Testing Market was valued at USD 177.96(Revenue in USD Million) in 2021.
China Pharmacogenetic Testing Market is projected to grow at a CAGR of 14.17% during the forecast period of 2024 to 2032.
The estimated market value of the China Pharmacogenetic Testing Market for final year is USD 381.31 (USD Million).
China Pharmacogenetic Testing Market Company Profiling
Frequently Asked Questions
The China Pharmacogenetic Testing Market is segmented based on Segmentation Type,Gene,Distribution Channel,End User,Therapeutic Area,Sample,Drug,Application.
China Pharmacogenetic Testing Market was valued at USD 177.96(Revenue in USD Million) in 2021.
China Pharmacogenetic Testing Market is projected to grow at a CAGR of 14.17% during the forecast period of 2024 to 2032.
The estimated market value of the China Pharmacogenetic Testing Market for final year is USD 381.31 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.